Abdominal distension with weight loss and high-protein ascites points beyond cirrhosis; raised ALT and childhood vaccines need structured checks.
High-protein portal hypertensive ascites should not be filed as cirrhosis.
Abdominal distension with weight loss, jaundice and peripheral oedema should not be filed under uncomplicated ascites. Open the Clinical Unknown case first: pain severity, volume status, liver chemistry and early imaging help separate simple fluid from hepatic venous outflow obstruction, cardiac amyloidosis and light-chain multiple myeloma. High-protein portal hypertensive ascites, raised JVP with clear lungs, low-voltage ECG with ventricular hypertrophy and a protein gap all change the next test or referral.
Raised ALT or AST in primary care needs context: metabolic risk, alcohol, blood-borne virus risk, ultrasound, FIB-4 and cardiovascular prevention. Childhood vaccines is the quick safety check for current schedule, live vaccines and post-MenB fever. Before choosing a pathway, write how each abnormal result fits the patient’s volume status, metabolic risk or age.
Open this first when abdominal distension comes with weight loss, jaundice and oedema. High-protein portal hypertensive ascites, raised JVP with clear lungs, low-voltage ECG with ventricular hypertrophy and protein gap should move the case towards Budd-Chiari syndrome, cardiac amyloidosis and light-chain myeloma.
Raised ALT or AST during diabetes, hypertension or weight review should start a liver and cardiovascular risk conversation. Code MASLD when confirmed, check alcohol and blood-borne virus risk, calculate FIB-4, and use ELF, FibroScan or referral when fibrosis risk is higher.
Routine immunisation is a moving schedule, so age-matching matters before reassurance or administration. The quick check is live-vaccine caution in immunocompromised children, HPV cancer prevention before exposure, BCG for increased tuberculosis risk and MenB fever advice up to 48 hours.
Adjuvant kidney cancer treatment is for patients who may already be disease-free, so uncertainty matters. The discussion separates recurrence risk, disease-free survival, overall survival uncertainty, relapse timing after pembrolizumab and belzutifan toxicity, especially anaemia and hypoxia.
Milk expression at work is physiology, not a favour squeezed between clinics. Protected 20–30 minute breaks every 2–3 hours, room access and rota planning reduce risks to supply and complications from insufficient expression.
When abdominal distension appears with weight loss, jaundice and oedema, separate solid, liquid and gas before naming the cause. If ascites is high-protein or JVP is raised with clear lungs, pair paracentesis with cardiac assessment and hepatic vein imaging. Add protein gap and calcium to the notes.
What turns ascites away from a simple cirrhosis pathway?
A high serum-ascites albumin gradient with ascitic protein greater than 2.5 g/dL points towards portal hypertension with a cardiac or hepatic venous outflow component. Raised JVP, peripheral oedema and clear lungs strengthen that direction.
Which findings support amyloidosis and light-chain myeloma in the abdominal distension case?
Low voltage on ECG despite ventricular hypertrophy, apical sparing on strain imaging and delayed subendocardial enhancement support cardiac amyloidosis. A raised protein gap, hypercalcaemia and kappa light-chain excess point towards plasma cell dyscrasia and systemic amyloid disease.
How should raised ALT or AST with metabolic risk be handled in primary care?
Document metabolic risk, alcohol intake, blood-borne virus risk and previous trends, then arrange ultrasound and calculate FIB-4. Confirmed MASLD should be coded so cardiovascular prevention and fibrosis risk review remain visible.
.svg)